CXCR3 deletion aggravates corneal neovascularization in a corneal alkali-burn model

Shengguo Li1, Shuizhen Shi1, Fan Xia1

  • 1Department of Ophthalmology & Visual Sciences, University of Texas Medical Branch, Galveston, TX, USA.

Insights

The chemokine receptor CXCR3 normally protects the cornea from blood vessel growth after injury. Its absence worsens inflammation and corneal neovascularization, highlighting a novel protective role.

Area of Science:

  • Ophthalmology
  • Immunology
  • Vascular Biology

Background:

  • Corneal neovascularization (CNV) leads to vision loss and blindness.
  • Current anti-inflammatory treatments for CNV have limited efficacy.
  • Chemokine-receptor interactions are critical in inflammatory responses.

Purpose of the Study:

  • To investigate the role of chemokine receptor CXCR3 in corneal neovascularization following alkali burn.
  • To elucidate the specific mechanisms by which CXCR3 influences inflammatory cell recruitment and neovascularization.

Main Methods:

  • Alkali burn model in wild-type (WT) and CXCR3 knockout (CXCR3-/-) mice.
  • Analysis of corneal hemangiogenesis and lymphangiogenesis.
  • Assessment of leukocyte infiltration, leukostasis, inflammatory cytokines, and angiogenic factors.
  • Bone marrow transplantation studies to determine the role of CXCR3 in bone marrow-derived cells.

Main Results:

  • CXCL10 and CXCR3 expression increased post-alkali burn.
  • CXCR3-/- mice showed exacerbated corneal hemangiogenesis and lymphangiogenesis.
  • Increased leukocyte infiltration, leukostasis, and inflammatory/angiogenic factors were observed in CXCR3-/- corneas.
  • Deletion of CXCR3 in bone marrow-derived leukocytes accelerated CNV.

Conclusions:

  • CXCR3 upregulation acts as a protective mechanism against corneal neovascularization after alkali burn.
  • CXCR3 plays a crucial role in maintaining corneal avascularity by modulating inflammation.
  • Targeting CXCR3 pathways may offer novel therapeutic strategies for CNV.

Related Concept Videos